I believe this is the first drug that has actually shown verifiable disease modification in clinical trials. TEVA's "Adagio" trial was a year and a half long trial in 14 countries, based on protocol design suggestions from the FDA.

If the FDA approves this application, this is the first approved disease modifying drug for PD, which in and of itself is a big event.

Maybe some have had adverse reactions to it, but this is still a major milestone and something to be cheered.

Just my humble opinion.

Oh, and hello everyone.